Rare disease drugs will be consigned for manufacturing by domestic pharmaceutical companies
Domestic pharmaceutical companies will be able to consign manufacturing of rare disease drugs and pharmaceutical products that are promptly required to be introduced in Korea.
On the 24th, the Ministry of Food and Drug Safety gave an administrative notice of the Amendment to the Pharmaceutical A...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
